Todd A. Fredrickson
Impact in
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Receptor Mechanisms and Signaling
Papers in
-
- Renal and related cancers 4
- Receptor Mechanisms and Signaling 3
- Epigenetics and DNA Methylation 2
-
- Renin-Angiotensin System Studies 4
- Co-authors
- Erding Hu (5 shared papers)Zunxuan Chen (4 shared papers)David P. Brooks (12 shared papers)Chiu-Mei Sung (1 shared paper)James D. Winkler (1 shared paper)Kyung Johanson (1 shared paper)Guifeng Zhang (1 shared paper)Ronggang Liu (1 shared paper)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Nephron Experimental Nephrology (2 papers)Pharmacology (1 paper)American Journal of Physiology-Renal Physiology (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)
- Partner nations
- United StatesFranceItaly
In The Last Decade
Todd A. Fredrickson
15 papers receiving 465 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 360
- Nephrology 37
- Geriatrics and Gerontology 15
- Oncology 79
- Cardiology and Cardiovascular Medicine 57
Countries citing papers authored by Todd A. Fredrickson
This map shows the geographic impact of Todd A. Fredrickson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd A. Fredrickson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd A. Fredrickson more than expected).
Fields of papers citing papers by Todd A. Fredrickson
This network shows the impact of papers produced by Todd A. Fredrickson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd A. Fredrickson. The network helps show where Todd A. Fredrickson may publish in the future.
Co-authors
The 25 scholars most cited alongside Todd A. Fredrickson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 241 | |
| 2 | 1992 | 39 | |
| 3 | 1998 | 37 | |
| 4 | 2001 | 34 | |
| 5 | 2000 | 33 | |
| 6 | 1998 | 17 | |
| 7 | 1997 | 17 | |
| 8 | 1991 | 15 | |
| 9 | 1995 | 13 | |
| 10 | 2000 | 12 | |
| 11 | 1998 | 10 | |
| 12 | 2001 | 5 | |
| 13 | 1999 | 5 | |
| 14 | Use of ameroid constrictors in the development of renin-dependent hypertension in dogs. | 1992 | 5 |
| 15 | 1992 | 2 |
About Todd A. Fredrickson
Todd A. Fredrickson is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Genetics, Nephrology and Pathology and Forensic Medicine, having authored 15 papers that have together received 485 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Renin-Angiotensin System Studies (4 papers), Receptor Mechanisms and Signaling (3 papers), Genetic and Kidney Cyst Diseases (2 papers), Neuropeptides and Animal Physiology (2 papers), Epigenetics and DNA Methylation (2 papers), Biomedical Research and Pathophysiology (2 papers) and Hormonal Regulation and Hypertension (2 papers). The work is most often cited by research in Molecular Biology (360 citations), Nephrology (37 citations), Geriatrics and Gerontology (15 citations), Oncology (79 citations) and Cardiology and Cardiovascular Medicine (57 citations). Todd A. Fredrickson has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Erding Hu, Zunxuan Chen, David P. Brooks, Chiu-Mei Sung, James D. Winkler, Kyung Johanson, Guifeng Zhang, Ronggang Liu, Robert B. Kirkpatrick and Yuan Xiao Zhu. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Nephron Experimental Nephrology, Pharmacology, American Journal of Physiology-Renal Physiology and Naunyn-Schmiedeberg s Archives of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.